| Literature DB >> 29223072 |
Yasuo Miki1, Shuji Shimoyama2, Tomoya Kon3, Tatsuya Ueno3, Ryo Hayakari4, Kunikazu Tanji5, Tomoh Matsumiya4, Eiki Tsushima6, Fumiaki Mori5, Koichi Wakabayashi5, Masahiko Tomiyama3.
Abstract
Previous postmortem studies demonstrated dysregulation of autophagy in patients with Parkinson's disease (PD). To clarify whether this alteration reflects a fundamental aspect of PD or represents the final stage of autophagy dysregulation resulting from a long neurodegenerative process, we focused on basal autophagy in peripheral blood mononuclear cells (PBMCs) of PD patients (n = 35) and controls (n = 23). The whole-transcriptome assay revealed downregulation of mRNAs for 6 core regulators of autophagy (UNC-51-like kinase [ULK] 3, autophagy-related [Atg] 2A, Atg4B, Atg5, Atg16L1, and histone deacetylase 6). Reverse transcription-polymerase chain reaction and Western blot analysis confirmed significantly increased protein levels of upstream autophagy (ULK1, Beclin1, and autophagy/beclin1 regulator 1) with negative feedback of mRNA expression for these proteins in PD. These protein levels were correlated with increased levels of α-synuclein in PBMCs. The expression level of the oligomeric form of α-synuclein in PBMCs paralleled the clinical severity of PD and the degeneration of cardiac sympathetic nerves. Basal activity of autophagy can be lower in patients with PD. Alteration of basal autophagy may be a fundamental aspect of PD.Entities:
Keywords: Autophagy; Parkinson's disease; Peripheral blood mononuclear cell; α-synuclein
Mesh:
Substances:
Year: 2017 PMID: 29223072 DOI: 10.1016/j.neurobiolaging.2017.11.006
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673